Wednesday, April 10, 2024 8:32:28 PM
For all that time up until about a couple of years ago, I urged that investors trade the stock and not own it…
It didn’t matter to me what the ceo or anyone else said…I rely on the available info and common sense…along with the charts…I would have relied on the fundamentals, but Kblb didn’t have any…and personally, I NEVER trust ANY ceo or executive of any company…no matter who they are or what company it is…
“ Having been burned by his announcements on multiple occasions, I’m not so easily trusting what he says now. ”
You don’t have to trust…you should look at what has changed, what progress has been made, all the legit expert personal involved and WILLING to be involved, the silk produced, the countries and entities who should have knowledge of what is going on who have climbed on board the Kblb train…
There is simply too much evidence and proof that Kblb is headed toward success to wallow in bitterness…you were trusting when you shouldn’t have been and now you are distrusting when everything including common sense is telling you that you shouldn’t be…
“ You think I should simply abandon the past.”
Yes…that’s exactly what I am saying…get over it…in the end, it’s not on Kim, it’s on you…
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM